Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 1
1999 3
2001 1
2002 1
2006 4
2007 1
2008 5
2009 5
2010 8
2011 11
2012 4
2013 12
2014 13
2015 8
2016 16
2017 4
2018 12
2019 15
2020 8
2021 12
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Sickle Cell Disease.
Pecker LH, Lanzkron S. Pecker LH, et al. Among authors: lanzkron s. Ann Intern Med. 2021 Jan;174(1):ITC1-ITC16. doi: 10.7326/AITC202101190. Epub 2021 Jan 12. Ann Intern Med. 2021. PMID: 33428443 Review.
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J; HOPE Trial Investigators. Vichinsky E, et al. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14. N Engl J Med. 2019. PMID: 31199090 Clinical Trial.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: lanzkron s. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
The reply.
Naik RP, Streiff MB, Lanzkron S. Naik RP, et al. Among authors: lanzkron s. Am J Med. 2013 Oct;126(10):e15. doi: 10.1016/j.amjmed.2013.06.006. Am J Med. 2013. PMID: 24054961 No abstract available.
Kneeling Was the First Step for Sickle Cell Disease.
Desai P, Little J, Kanter J, Bridges K, Andemariam B, Lanzkron S. Desai P, et al. Among authors: lanzkron s. Ann Intern Med. 2021 Jul;174(7):1004-1005. doi: 10.7326/M20-7418. Epub 2021 Mar 23. Ann Intern Med. 2021. PMID: 33750189 No abstract available.
Pain without gain: steroids and sickle crisis.
Lanzkron S, Pecker L. Lanzkron S, et al. Blood. 2022 Jun 30;139(26):3678-3679. doi: 10.1182/blood.2022016070. Blood. 2022. PMID: 35771559 No abstract available.
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
Liem RI, Lanzkron S, D Coates T, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA. Liem RI, et al. Among authors: lanzkron s. Blood Adv. 2019 Dec 10;3(23):3867-3897. doi: 10.1182/bloodadvances.2019000916. Blood Adv. 2019. PMID: 31794601 Free PMC article.
146 results